Skip to main content
OpenTrials
Completed

NCT Number: NCT02042638

The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Idiopathic Hypogonadotropic Hypogonadism

Age range

16 year–45 year

Sex eligibility

Male

Study type

Observational

Primary location

Gulhane School of Medicine Dep. of Endocrinology and Metabolism

Ankara, 06018, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -

Exclusion criteria

Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies

-

Treatment and study plan

hCG 1500 IU three times a week

Drug

Other names: Pregnyl (Organon) ampule 1500 IU

Pregnyl (hCG) ampule 1500 IU/three times a week

Drug

Primary outcomes

  1. HDL after hCG treatment

    Time frame: 2011-2013

    2011-2013

  2. LDL levels after hCG treatment

    Time frame: 2011-2013

  3. total cholesterole levels after hCG treatment

    Time frame: 2011-2013

Secondary outcomes

  1. Body fat ratio after hCG treatment

    Time frame: 2011-2013

  2. hsCRP levels after hCG treatment

    Time frame: 2011-2013

Sponsors and collaborators

Lead sponsor

Gulhane School of Medicine

Other

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jan 23, 2014
Registry last updated
Jan 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.